


Axel P. Schulz
Axel is the Executive Partner of the Brussels office. He supports clients in a broad range of German and European Commission competition law matters. Regularly called upon to head up teams of the Firm’s lawyers, Axel is noted for his skill in coordinating advice across multiple offices and territories, to provide his clients with clear and creative solutions to their problems. Axel’s significant track record includes a number of high-profile competition cases, such as ’Toshiba v. Commission’ – in which the General Court of the European Union annulled in full the €90.9 million fine imposed on Toshiba by the European Commission, for its alleged participation in the Gas Insulated Switchgear cartel. He also worked on Toshiba’s Cathode Ray Tube appeal, as well as the oral hearings in T-113/07 before the European Court of Justice, and the Transformers (Case COMP/39.129) hearing before the General Court.
Distinctions
Nominee, 2019 Antitrust Writing Awards: Business, Procedure.
Nominee, 2019 Antitrust Writing Awards: Business, Mergers.
Nominee, 2019 Antitrust Writing Awards: Business, Unilateral Conduct.
Nominee, 2018 Antitrust Writing Awards: Business, Unilateral Conduct.
Nominee, 2017 Antitrust Writing Awards: Business, Mergers.
Nominee, 2016 Antitrust Writing Awards: Business, Private Enforcement.
Nominee, 2015 Antitrust Writing Awards: Business, Mergers.
Winner, 2014 Antitrust Writing Awards: Business, Private Enforcement.
Winner, 2012 Antitrust Writing Awards: Business, Anticompetitive Practices






Linked authors
1169 | Events

Articles
4731 Bulletin
204
On 18 May 2022, the EU General Court (GC) upheld the European Commission’s (EC) € 28 million fine imposed on Canon for gun-jumping in the context of a (somewhat unique) so-called warehousing structure. The judgment confirms that structures such as the one at issue are not allowed under EU law (...)
242
On 23 February 2022, the EU’s General Court (GC) dismissed a €1.7 billion claim for damages brought by United Parcel Service Inc. (UPS) against the European Commission (EC). UPS sought compensation for the losses resulting from the EC’s decision to block UPS’ merger with TNT NV (TNT). The GC, (...)
402
The German Bundeskartellamt and the Austrian Bundeswettbewerbsbehörde have updated their joint guidance on the application of their respective transaction value thresholds for mandatory merger notifications (the "Guidelines") on December 23, 2021. The authorities initially published the (...)
212
Competition authorities have been traditionally reluctant to pursue excessive pricing cases since many of them had failed on the facts. However, in recent years, there has been a resurgence of the topic in pharma-related cases. In particular, the national competition authorities have led the (...)
379
On 5 May 2021, the European Commission ("Commission") issued a proposal for a far-reaching Regulation to tackle foreign subsidies, which, if adopted, will increase the regulatory risk for companies operating or investing in the EU with backing from non-EU States. The new instrument targets (...)
67
On 9 September 2020, the French Competition Authority (FCA) imposed fines totalling €444 million on three laboratories (Novartis, Roche and Genentech) for having abused their collective dominant position in the market for the treatment of age-related macular degeneration (AMD). The facts that (...)
219
Last week, in response to the outbreak of the Coronavirus disease (COVID-19), the antitrust agencies in the United States and European Union issued policies that will affect, and may delay, merger filings and reviews. On March 13, 2020, the US Department of Justice (“DOJ”) and Federal Trade (...)
255
COVID-19 is changing our lives more rapidly and more profoundly than we could have ever imagined. All over the world, governments order their countries into lockdowns, factories stop producing, people stop buying, citizens are confined to their four walls and businesses switch to working (...)
39
On 14 March 2019, the CMA decided to close its investigation into pharmaceutical company MSD’s discount scheme for the medicine Remicade, concluding that it was not likely to limit competition. Previously, the CMA had issued a statement of objections, alleging that MSD abused its dominant (...)
106
On 12 July 2018, the EU’s General Court handed down 12 judgments relating to the power cables case. Among these was a judgment which confirmed that a parent company able to exercise all the voting rights in a subsidiary is presumed liable for any infringement of the EU competition rules by that (...)
829
This article has been nominated for the 2018 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On 6 September 2017, the Court of Justice of the European Union ("CJEU" or "Court") essentially held in Intel that the European Commission ("Commission") cannot (...)
948
Introduction On 10 March 2016, the European Court of Justice issued a landmark ruling annulling European Commission decisions requesting information from cement manufacturers, on the ground that the decisions did not sufficiently explain why the information requested was necessary . This (...)
208
The level of fines imposed by the European Commission in competition cases has attracted controversy for more than ten years. The often deferential approach of the European courts to hearing appeals has also been criticised, but in many cases the courts have largely left untouched the (...)
449
In a judgment delivered on 3 March 2011 in Cases T-117/07 Areva v European Commission and T-121/07 Alstom v European Commission, the General Court of the European Union (the ‘Court’) the Court confirmed the general rule that when a wholly-owned subsidiary that has infringed competition law is (...)
172
This article is the winner of the business category, anticompetitive practices section of the 2012 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. In an Opinion delivered on 10 February 2011, Advocate General (‘AG’) Sharpston of the European Court of (...)